BackgroundImmune checkpoint inhibitors (ICIs) have revolutionized the treatment of various malignancies. particularly melanoma. However. immune-related adverse events (irAEs) pose significant challenges. https://herbsdailyes.shop/product-category/nutritionals-pediatric/